The Gluten-Free Probiotics Market Size is valued at 54.00 Billion in 2023 and is predicted to reach 89.31 Billion by the year 2031 at an 6.73 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The growing incidence of gluten intolerance and celiac disease globally is a major driver for the gluten-free probiotics market.
- Consumers are becoming increasingly familiar of the importance of gut health & the benefits of probiotics, leading to a surge in demand for gluten-free probiotic products.
- North America dominated the market and accounted for a global revenue share in 2023.
- A key challenge for the Gluten-Free Probiotics Market is the presence of regulatory hurdles.
Along with many other health advantages like enhancing immunity, preserving gut health, managing weight, preventing obesity, and many more, gluten-free probiotics aid with digestion. Customers are being drawn to a gluten-free diet by increased health consciousness among consumers and the new trend of veganism, which is anticipated to increase demand for plant-based goods. As a result, to broaden their customer base, several markets and significant market participants are launching gluten-free probiotics.
The gluten-free probiotics market is expected to be driven by expanding consumer awareness of preventative healthcare measures and rising demand for natural and safe health-benefiting products. A beneficial element for market expansion is anticipated to be the numerous initiatives and increased efforts made by professional groups and organizations to encourage customers to buy these items. The expanding body of research pointing to the product's health advantages and the rising acceptance of probiotic strains as a natural, affordable, and secure alternative to pharmaceutical treatments are expected to benefit market expansion.
The epidemic's logistical and related economic effects are currently posing challenges to the worldwide economy. Despite these outside influences, a healthier demand growth rate for health and immune-boosting products is anticipated. The importance of dietary supplements and functional foods in promoting greater health and wellness is now better understood by consumers. As a result, these products are growing in popularity due to their numerous health benefits, including improving immune function and gut health, which will spur market expansion in the near future.
Competitive Landscape
Some Major Key Players In The Gluten-Free Probiotics Market:
- DuPont (Danisco),
- Hansen,
- Lallemand,
- China-Biotics,
- Nestle,
- Danone,
- Probi,BioGaia,
- Yakult,
- Novozymes,
- Glory Biotech,
- Ganeden,
- Morinaga Milk Industry,
- Sabinsa, Greentech,
- Biosearch Life,
- UAS Laboratories
Market Segmentation:
The Gluten-Free Probiotics market is segmented by type and application. Based on type, the market is segmented into Bifidobacterium, Lactobacillus and Other. Based on the application, Gluten-Free Probiotics are segmented into Food & Beverage, Drugs, Dietary Supplements and Others.
Based On Type, The Lactobacillus Segment Is Accounted As A Major Contributor To The Gluten-Free Probiotics Market.
Based on type, the market is segmented into Bifidobacterium, Lactobacillus and Other. Lactobacillus held the highest market share for gluten-free probiotics. The ability of lactobacillus strains to suppress the growth of germs and pathogens is beneficial for extending the shelf life and improving the hygienic excellence of foods. Because of their capacity to lower gastrointestinal disorders in humans, Lactobacillus strains are advantageous to people, which is expected to affect product demand positively.
The Food & Beverage Segment Witnessed Growth At A Rapid Rate.
Based on the application, Gluten-Free Probiotics are segmented into Food & Beverage, Drugs, Dietary Supplements and Others. Currently, foods & beverages are ingested regularly and have been shown to give possible health benefits above and beyond the generally acknowledged nutritional impacts. One of the current global food trends is consuming foods & beverages. Sales are driven by the rising demand for natural and healthy food products. It is anticipated that the demand for dietary supplements that fulfil consumer needs will increase due to consumers' growing understanding of the benefits of a healthy, balanced diet in reducing illness risk and maintaining overall health.
The Asia Pacific Gluten-Free Probiotics Market Holds A Significant Revenue Share In The Region.
The Asia Pacific Gluten-Free Probiotics market is expected to register the highest market share in revenue in the near future. With China and Japan accounting for more than half of regional sales, the region has developed quickly. In Japan and other countries in Central and Southeast Asia, the demand for gluten-free probiotic products, particularly drinks, is anticipated to stay strong in the future. For instance, Yakult Honsha, a corporation with headquarters in Japan, claims to sell 9,540 bottles of Yakult every day in that country. The rising demand for these fermented beverages will promote regional market expansion. In addition, North America is projected to increase in the global Gluten-Free Probiotics market. The region's food industry is well-established, there are notable companies, and the prevalence of lifestyle-related diseases like diabetes and obesity is rising, driving consumers to adopt healthy eating habits. This is anticipated to increase product sales in the region.
Recent Developments:
- In Nov 2022, Novozymes, the global frontrunner in biological solutions, worked together with customers, partners, and the global community to discover biological solutions for conserving the Earth's resources and improving quality of life. Novozymes OneHealth, a platform dedicated to human health growth, offers scientifically validated supplements and consumer health products that contribute to improved well-being and healthier lifestyles. By embracing a forward-thinking approach, Novozymes OneHealth aims to redefine the future of human health.
Gluten-Free Probiotics Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2023 |
USD 54.00 Billion |
Revenue Forecast In 2031 |
USD 89.31 Billion |
Growth Rate CAGR |
CAGR of 6.73 % from 2024 to 2031 |
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
Historic Year |
2019 to 2023 |
Forecast Year |
2024-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
Type, Application |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
DuPont (Danisco), Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi,BioGaia, Yakult, Novozymes, Glory Biotech, Ganeden, Morinaga Milk Industry, Sabinsa, Greentech, Biosearch Life, UAS Laboratories and Synbiotech. |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |